Join
Live feed
·
PRReleasevia Quantisnow
Impact BioMedical Inc. logo

CORRECTED — Impact Biomedical Inc (NYSE: IBO) Announces 1 for 12.62 Reverse Stock Split to Pursue Completion of Merger with Zoar Limited (f/k/a Dr Ashleys Limited)

ByQuantisnow·Wall Street's wire, on your screen.
IBO· Impact BioMedical Inc.
Health Care

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track IBO (Impact BioMedical Inc.) and more on Quantisnow.